Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combining urinary DNA methylation and cell-free microRNA biomarkers for improved monitoring of prostate cancer patients on active surveillance

16 Feb 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to Prostate Cancer Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 30777394
DOI: 10.1016/j.urolonc.2019.01.031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combining urinary DNA methylation and cell-free microRNA biomarkers for improved monitoring of prostate cancer patients on active surveillancePMID 30777394Read ↗

New Progress of Epigenetic Biomarkers in Urological CancerSemantic proximity Read ↗

Methylation and MicroRNA Profiling to Understand Racial Disparities of Prostate Cancer.Semantic proximity Read ↗

Epigenetic biomarkers in urological tumors: A systematic review.Semantic proximity Read ↗

Identification of Methylation Biomarkers for Early Detection of Prostate CancerSemantic proximity Read ↗

A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNASemantic proximity Read ↗

Epigenetic Markers for Molecular Detection of Prostate CancerSemantic proximity Read ↗

Advances in Urinary Biomarkers for the Early Detection of Urological Cancers: From Proteins and Epigenetics to Gene Mutations.Semantic proximity Read ↗

Evaluation of Sensitive Urine DNA-Based PENK Methylation Test for Detecting Bladder Cancer in Patients with HematuriaSemantic proximity Read ↗

Epigenetic biomarkers in prostate cancer: Current and future uses.Semantic proximity Read ↗

Epigenetics-Based Diagnostic and Therapeutic Strategies: Shifting the Paradigm in Prostate CancerSemantic proximity Read ↗

Unlocking the potential of tumor‐derived DNA in urine for cancer detection: methodological challenges and opportunitiesSemantic proximity Read ↗

Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and SurveillanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.